Fundraising FoxAlcyonetx
Acquired1 known investors
Find your way into Alcyonetx
Sign up to see every warm intro you have to Alcyonetx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alcyonetx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biogen develops and markets therapies for spinal muscular atrophy (SMA), including FDA-approved treatments and the investigational ThecaFlex DRx System, an implantable intrathecal drug delivery device. The company serves patients and families affected by SMA and other neuromuscular conditions globally.
Investors · 1
Frequently asked questions
- What does Alcyonetx do?
- Biogen develops and markets therapies for spinal muscular atrophy (SMA), including FDA-approved treatments and the investigational ThecaFlex DRx System, an implantable intrathecal drug delivery device. The company serves patients and families affected by SMA and other neuromuscular conditions globally.
- Who are Alcyonetx's investors?
- Alcyonetx's investors include Harbor Light Capital Partners.